Angiotensinogen Promoter Sequence Variants in Essential Hypertension
Open Access
- 1 December 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 19 (12) , 1278-1285
Abstract
Essential hypertension is a complex multifactorial disease caused by ill-defined genetic factors. The angiotensinogen (AGT) gene has been implicated as a risk factor in essential hypertension. To assess the role of AGT in hypertension, we evaluated two polymorphisms (A-6G and C-20A) in the 5′ region of the gene that have been shown to have a role in transcriptional regulation. A total of 463 subjects were studied: 243 African Americans (26 male and 34 female normotensives, 66 male and 117 female hypertensives) and 220 whites (35 male and 60 female normotensives, 55 male and 70 female hypertensives). African American and white subjects were examined individually, as significant differences in allele and genotype frequencies were observed between these two cohorts. White female hypertensives and normotensives differed significantly in genotype frequency at C-20A (P = .02). No other single site comparisons were significantly different between hypertensives and normotensives in either the white or African American samples. Haplotype frequencies in white males also differed significantly between phenotypic classes (P = .05). To evaluate the data further, we assessed all polymorphic sites simultaneously by the examination of multisite interaction and determined the single best genetic model for each population. A model that included both sites and gender correctly predicted hypertension status in the white population 59.1% of the time (P = .039). The model generated for the African American population was not significant. Our results suggest that a complex set of genetic factors interact with gender to predispose whites to hypertension.Keywords
This publication has 23 references indexed in Scilit:
- A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activityJournal of Molecular Medicine, 2005
- The use of animal models in the study of complex disease: all else is never equal or why do so many human studies fail to replicate animal findings?BioEssays, 2004
- An association study of angiotensinogen polymorphisms with serum level and hypertension in an African-American populationJournal Of Hypertension, 2003
- Angiotensinogen Gene Polymorphism at −217 Affects Basal Promoter Activity and Is Associated with Hypertension in African-AmericansJournal of Biological Chemistry, 2002
- Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated IndividualsHuman Heredity, 2002
- Faster Haplotype Frequency Estimation Using Unrelated SubjectsHuman Heredity, 2002
- Multifactor-Dimensionality Reduction Reveals High-Order Interactions among Estrogen-Metabolism Genes in Sporadic Breast CancerThe American Journal of Human Genetics, 2001
- Polymorphism in oestrogen response element associated with variation in plasma angiotensinogen concentrations in healthy pregnant womenJournal Of Hypertension, 2000
- Orphan receptor Arp-1 binds to the nucleotide sequence located between TATA box and transcriptional initiation site of the human angiotensinogen gene and reduces estrogen induced promoter activityMolecular and Cellular Endocrinology, 1999
- Haplotypes of Angiotensinogen in Essential HypertensionThe American Journal of Human Genetics, 1997